tradingkey.logo

BRIEF-Bluebird Bio Announces Definitive Agreement To Be Acquired By Carlyle And SK Capital

ReutersFeb 21, 2025 2:12 PM

- bluebird bio Inc BLUE.O:

  • BLUEBIRD BIO ANNOUNCES DEFINITIVE AGREEMENT TO BE ACQUIRED BY CARLYLE AND SK CAPITAL

  • BLUEBIRD BIO INC - STOCKHOLDERS TO RECEIVE $3.00 PER SHARE IN CASH

  • BLUEBIRD BIO INC - DAVID MEEK EXPECTED TO BECOME CEO OF BLUEBIRD UPON CLOSING OF DEAL

  • BLUEBIRD BIO INC - STOCKHOLDERS TO RECEIVE CONTINGENT VALUE RIGHT OF $6.84 PER SHARE FROM DEAL

  • BLUEBIRD BIO: ENTERED INTO AMENDMENTS TO LOAN AGREEMENT WITH HERCULES CAPITAL TO FACILITATE ADEQUATE LIQUIDITY

Source text: ID:nBwb7M3fsa

Further company coverage: BLUE.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI